ValleyDAO

ValleyDAO

Live
Curated
DAO
Synthetic Biology

ValleyDAO is a decentralized platform revolutionizing funding and translation for synthetic biology research to combat climate change. By empowering a global community with tokenized IP frameworks, we drive impactful biotech innovations from labs to market, fostering real-world climate solutions minus the greenwashing.

...
Community Size
...
Growth Rate
$GROW
ETH
Powered by TradingView & GeckoTerminal
Market Details
Lock
Staking Available

Synthetic biology has the potential to revolutionize sustainable production across food, energy, chemicals, and materials, paving the way for a future of material abundance that benefits both people and the planet.

+3.1°C

Predicted global temperature increase by end of this century

80%

Majority of synthetic biology funding flows to health, leaving climate application funding only at 20%

$3.4T

Synthetic biology market potential by 2030 for non-medicine applications

Project

Additional Documentation

Pitch Deck

Synthetic biology is revolutionizing our ability to engineer life, enabling the design of microorganisms and plants to address global challenges such as CO2 pollution, sustainable food production, and environmental clean-up.


This field integrates advanced technologies like CRISPR gene editing, metabolic engineering, and bioinformatics to reprogram living cells into nanofactories that can:


- Remove CO2, heavy metals, and toxins from the environment.

- Manufacture bio-based construction materials with improved strength and functionality.

- Create biodegradable plastics and sustainable textiles.

- Enhance crop yields and nutritional content through.

- Synthesize bio-inks for 3D printing living tissues and organs.


Through its decentralized model, ValleyDAO empowers a global community to co-fund and collaborate on synthetic biology innovations, bridging science with a token-incentivized talent network to accelerate real-world impact. Its novelty lies in using IP Tokens and the GROW token to align incentives. IP Tokens let the community share in project success, while GROW enables voting on funding, rewards for co-development, and exclusive access to IP Token launches, aligning stakeholders toward shared goals.

Albert Anis

Albert brings deep expertise in synbio research, and tech commercialization, having worked on artificial cells, and built innovation ecosystems and communities for leading synbio stakeholders like iGEM Startups and the Novo Nordisk-funded BII. He's advised and worked with 50+ synbio startups.

Morgan Richards

Morgan proficiency is in systems design and human coordination, with a specialization in AI and tools for DeSci. At ValleyDAO, he spearheads product development where he’s building Phlo: An AI powered commercialization platform for academics in climate biotechnology.

Dan Hussey

Dan contributes over a decade of experience in intellectual property management, licensing, and portfolio planning, establishing critical frameworks for repeatable interactions with Tech Transfer Offices globally.

John Cumbers

John is the founder of SynBioBeta, a leading conference using synthetic biology to build a better, more sustainable world. He brings over two decades of industry experience, supporting ValleyDAOs DeSci and synthetic biology strategy.

Updates

Feed
...

Stay up to date

Get the latest community updates and find out about upcoming ValleyDAO developments